Company page

Mannkind Corporation

Mannkind Corporation, trading under the ticker MNKD, is a public company based in the United States with a market capitalization of approximately $1.22 billion. The company focuses on developing and commercializing innovative therapeutic products for diabetes and other diseases. Mannkind's lead product is Afrezza, an inhalable insulin for diabetes management.